As of Oct 09
| -0.33 / -0.75%|
The 16 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 47.20, with a high estimate of 59.59 and a low estimate of 39.16. The median estimate represents a +7.67% increase from the last price of 43.84.
The current consensus among 16 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.